Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10648408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  CD133+ Cell Therapy for Refractory Coronary Heart Disease
Condition: Coronary Artery Disease
Intervention: Procedure: Intracoronary Infusion of CD133+ Cells
2 Terminated A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Condition: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF
Intervention: Biological: CD133+ cells transplant

Indicates status has not been verified in more than two years